Graf Akcie OCUL (Ocular Therapeutix Inc). Diskuze k akciím OCUL. Aktuální informace OCUL.

Základní informace o společnosti Ocular Therapeutix Inc (Akcie OCUL)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	880.41M
Hodnota podniku (EV)	N/A
Tržby	32.285M
EBITDA	N/A
Zisk	-102.92
Růst v tržbách Q/Q	646.85 %
Růst v tržbách Y/Y	344.51 %
P/E (Cena vůči ziskům)	0.00
Forward P/E	-0.14
EV/Sales	18.97
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	N/A
Price/Sales	27.27
P/FCF	N/A
Price/Book	11.57
Účetní hodnota na akcii	0.97
Hotovost na akcii	2.92
FCF vůči ceně	-6.60 %
Počet zaměstnanců	181
Tržba na zaměstnance	178.370k
Profit margin	-894.31 %
Operating margin	-213.13 %
Gross margin	88.03 %
EBIT margin	-297.79 %
EBITDA margin	-676.46 %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	-82.81 %
EPS - Očekávaný růst příští rok	19.05 %
Return on assets	-49.37 %
Return on equity	-174.71 %
ROIC	-87.41 %
ROCE	-45.97 %
Dluhy/Equity	2.44
Čistý dluh/EBITDA	0.31
Current ratio	10.05
Quick Ratio	10.00
Volatilita	5.85
Beta	1.29
RSI	55.03
Cílová cena analytiků	16
Známka akcie (dle analytiků)	1.33
Insider ownership	0.39 %
Institutional ownership	64.87 %
Počet akcií	76.583M
Procento shortovaných akcií	8.38 %
Short ratio	7.17 %
Dividenda	N/A
Procentuální dividenda	N/A %
Dividenda/Zisk	N/A %
Obchodovaná od	2014
Země	United States

Finanční výsledky akcie OCUL

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	$4.227	$1.99	$1.923	$1.887	$1.75	$0.772	-	$0.01
Cost Of Goods Sold	$2.325	$0.465	$0.457	$0.443	$0.319	$0.091	-	$0.007
Gross Profit	$1.902	$1.525	$1.466	$1.444	$1.431	$0.681	-	$0.003
Research And Development Expenses	$41.091	$36.915	$30.88	$27.065	$26.611	$18.88	$10.517	$11.54
SG&A Expenses	$46.613	$23.728	$32.509	$17.705	$13.017	$8.895	$2.386	$2.134
Other Operating Income Or Expenses	-	-	-	-	-	-	-	-
Operating Expenses	$90.029	$61.108	$63.846	$45.213	$39.947	$27.866	$12.903	$13.681
Operating Income	$-85.802	$-59.118	$-61.923	$-43.326	$-38.197	$-27.094	$-12.903	$-13.671
Total Non-Operating Income/Expense	$-0.57	$-0.86	$-1.463	$-1.377	$-1.551	$-1.554	$-0.414	$-0.422
Pre-Tax Income	$-86.372	$-59.978	$-63.386	$-44.703	$-39.748	$-28.648	$-13.317	$-14.093
Income Taxes	-	-	-	-	-	-	-	-
Income After Taxes	$-86.372	$-59.978	$-63.386	$-44.703	$-39.748	$-28.648	$-13.317	$-14.093
Other Income	-	-	-	-	-	-	-	-
Income From Continuous Operations	$-86.372	$-59.978	$-63.386	$-44.703	$-39.748	$-28.648	$-13.317	$-14.093
Income From Discontinued Operations	-	-	-	-	-	-	-	-
Net Income	$-86.372	$-59.978	$-63.386	$-44.703	$-39.748	$-28.659	$-13.344	$-14.128
EBITDA	$-83.272	$-56.832	$-60.281	$-42.259	$-37.16	$-26.523	$-12.499	$-13.267
EBIT	$-85.802	$-59.118	$-61.923	$-43.326	$-38.197	$-27.094	$-12.903	$-13.671
Basic Shares Outstanding	45	38	29	25	23	11	3	3
Shares Outstanding	45	38	29	25	23	11	3	3
Basic EPS	$-1.91	$-1.57	$-2.20	$-1.80	$-1.71	$-2.69	$-5.11	$-5.60
EPS - Earnings Per Share	$-1.91	$-1.57	$-2.20	$-1.80	$-1.71	$-2.69	$-5.11	$-5.60

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$54.437	$54.062	$41.538	$68.145	$105.064	$74.828
Receivables	$2.548	$0.201	$0.226	$0.25	$0.193	$0.329
Inventory	$0.954	$0.217	$0.122	$0.113	$0.134	$0.133
Pre-Paid Expenses	$2.231	$1.713	$1.453	$1.39	$1.592	$0.893
Other Current Assets	-	-	-	-	-	-
Total Current Assets	$60.17	$56.193	$43.339	$69.898	$106.983	$76.183
Property, Plant, And Equipment	$10.151	$10.236	$10.478	$3.313	$3.095	$1.782
Long-Term Investments	-	-	-	-	-	-
Goodwill And Intangible Assets	-	-	-	-	-	-
Other Long-Term Assets	$1.764	$6.614	$1.614	$1.728	$0.228	$0.228
Total Long-Term Assets	$18.57	$16.85	$12.092	$5.041	$3.323	$2.01
Total Assets	$78.74	$73.043	$55.431	$74.939	$110.306	$78.193
Total Current Liabilities	$12.029	$9.159	$13.426	$8.3	$5.378	$5.874
Long Term Debt	$49.312	$24.788	$12.471	$14.094	$15.272	$13.511
Other Non-Current Liabilities	$12.124	$3.221	-	-	-	-
Total Long Term Liabilities	$70.341	$28.009	$15.858	$14.631	$15.34	$13.623
Total Liabilities	$82.37	$37.168	$29.284	$22.931	$20.718	$19.497
Common Stock Net	$0.005	$0.004	$0.003	$0.003	$0.002	$0.002
Retained Earnings (Accumulated Deficit)	$-383.615	$-297.243	$-237.265	$-173.879	$-129.176	$-89.428
Comprehensive Income	-	-	-	$-0.005	$-0.068	-
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$-3.63	$35.875	$26.147	$52.008	$89.588	$58.696
Total Liabilities And Share Holders Equity	$78.74	$73.043	$55.431	$74.939	$110.306	$78.193

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-86.372	$-59.978	$-63.386	$-44.703	$-39.748	$-28.648
Total Depreciation And Amortization - Cash Flow	$2.53	$2.286	$1.642	$1.067	$1.037	$0.571
Other Non-Cash Items	$8.139	$7.88	$7.721	$7.559	$4.465	$5.419
Total Non-Cash Items	$10.669	$10.166	$9.363	$8.626	$5.502	$5.99
Change In Accounts Receivable	$-2.347	$0.025	$0.024	$-0.057	$0.136	$-0.06
Change In Inventories	$-0.737	$-0.095	$-0.009	$0.021	$-0.001	$-0.133
Change In Accounts Payable	$0.124	$-0.796	$0.932	$-0.159	$0.348	$0.507
Change In Assets/Liabilities	$-0.629	$-0.26	$0.045	$0.882	$-0.199	$-0.098
Total Change In Assets/Liabilities	$-1.875	$0.585	$3.55	$2.076	$0.503	$2.162
Cash Flow From Operating Activities	$-77.578	$-49.227	$-50.473	$-34.001	$-33.743	$-20.496
Net Change In Property, Plant, And Equipment	$-2.238	$-1.889	$-8.247	$-1.917	$-1.771	$-1.26
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-	-	-
Net Change In Short-term Investments	-	-	-	-	-	-
Net Change In Long-Term Investments	-	-	$35.2	$38.985	$-36.858	$-37.326
Net Change In Investments - Total	-	-	$35.2	$38.985	$-36.858	$-37.326
Investing Activities - Other	-	-	-	-	$0.06	-
Cash Flow From Investing Activities	$-2.238	$-1.889	$26.953	$37.068	$-38.569	$-38.586
Net Long-Term Debt	$37.275	$6.375	$2.4	-	$0.397	$12.604
Net Current Debt	-	-	-	-	-	-
Debt Issuance/Retirement Net - Total	$37.275	$6.375	$2.4	-	$0.397	$12.604
Net Common Equity Issued/Repurchased	$38.066	$62.265	$30.199	$1.104	$66.068	$69.617
Net Total Equity Issued/Repurchased	$38.066	$62.265	$30.199	$1.104	$66.068	$69.617
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	-	-	$-0.591	$-0.519	$-0.762	$-3.251
Cash Flow From Financial Activities	$75.341	$68.64	$32.008	$0.585	$65.703	$78.97
Net Cash Flow	$-4.475	$17.524	$8.488	$3.652	$-6.609	$19.888
Stock-Based Compensation	$8.759	$7.483	$7.321	$5.956	$4.64	$5.008
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	5.0021	6.1353	3.228	8.4214	19.8927	12.9695
Long-term Debt / Capital	1.0795	0.4086	0.3229	0.2132	0.1456	0.1871
Debt/Equity Ratio	-13.5846	0.691	0.689	0.3008	0.1705	0.2533
Gross Margin	44.9965	76.6332	76.2351	76.5236	81.7714	88.2124
Operating Margin	-2029.856	-2970.754	-3220.125	-2296.025	-2182.686	-3509.585
EBIT Margin	-2029.856	-2970.754	-3220.125	-2296.025	-2182.686	-3509.585
EBITDA Margin	-1970.002	-2855.879	-3134.738	-2239.48	-2123.428	-3435.622
Pre-Tax Profit Margin	-2043.34	-3013.97	-3296.204	-2368.998	-2271.314	-3710.881
Net Profit Margin	-2043.34	-3013.97	-3296.204	-2368.998	-2271.314	-3712.306
Asset Turnover	0.0537	0.0272	0.0347	0.0252	0.0159	0.0099
Inventory Turnover Ratio	2.4371	2.1429	3.7459	3.9204	2.3806	0.6842
Receiveable Turnover	1.6589	9.9005	8.5088	7.548	9.0674	2.3465
Days Sales In Receivables	220.0189	36.8668	42.8965	48.3572	40.2543	155.5505
ROE - Return On Equity	2379.411	-167.1861	-242.4218	-85.9541	-44.3675	-48.8074
Return On Tangible Equity	2379.391	-167.1861	-242.4217	-85.9541	-44.3676	-48.8074
ROA - Return On Assets	-109.6927	-82.1133	-114.3512	-59.6525	-36.0343	-36.6376
ROI - Return On Investment	-189.0723	-98.8708	-164.1359	-67.6273	-37.9058	-39.6748
Book Value Per Share	-0.0721	0.8641	0.8816	2.0783	3.6197	2.7513
Operating Cash Flow Per Share	-0.4221	0.4599	-0.3813	0.0816	0.4723	2.9227
Free Cash Flow Per Share	-0.4219	0.6965	-0.5902	0.0805	0.5143	2.9528

Premium

Tento článek patří k prémiovému obsahu našeho webu.

Již mám předplatné

Roční předplatné

Ušetříte 589 Kč oproti měsíčnímu předplatnému

2 999Kč

Objednat

Čtvrtletní předplatné

Ušetříte 98 Kč oproti měsíčnímu předplatnému

799Kč

Objednat

Měsíční předplatné

Předplatné našich prémiových služeb na měsíc.

299Kč

Objednat

Porovnání s konkurencí: Akcie OCUL

Společnost	P/E	PEG	Růst v tržbách (roční)	Růst v EPS	Return on equity	P/B	Profit margin
OCUL	0.00	N/A	344.51 %	19.05 %	-174.71 %	11.57	-894.31 %
Akcie ANIK	N/A	3.19	8.98 %	-53.33 %	-4.53 %	2.17	-18.38 %
Akcie HAE	55.05	2.20	-4.46 %	-1.61 %	9.23 %	4.87	9.13 %
Akcie SRDX	507.18	4.00	0.55 %	38.89 %	1.15 %	5.81	1.18 %
Akcie XENT	0.00	N/A	20.15 %	22.86 %	-112.75 %	13.46	-89.78 %

Nedávné obchody insiderů: Akcie OCUL

Jméno	Obchod	Cena	Objem
Amarpreet Sawhney President and CEO	Nákup 6 Jun 2019	$2.92	$363,447
Leslie J. Williams Director	Nákup 14 Jun 2019	$4.40	$19,800
Donald Notman Chief Financial Officer	Nákup 14 Jun 2019	$4.33	$10,825
Management Inc. Opaleye	Nákup 30 Dec 2019	$3.97	$79,400
Management Inc. Opaleye	Nákup 2 Jan 2020	$3.90	$58,500
Road Llc Summer 10% owner	Nákup 13 Mar 2020	$4.55	$4,345,532
Road Llc Summer 10% owner	Nákup 18 Mar 2020	$4.62	$1,782,572
Road Llc Summer 10% owner	Nákup 20 Mar 2020	$4.71	$513,861
Road Llc Summer 10% owner	Nákup 19 May 2020	$5.50	$1,999,998
Road Llc Summer 10% owner	Nákup 16 Oct 2020	$10.48	$4,580
Bruce Peacock Director	Option 3 Dec 2020	$5.09	$127,250

JenAkcie

Graf Akcie OCUL (Ocular Therapeutix Inc). Diskuze k akciím OCUL. Aktuální informace OCUL.

Základní informace o společnosti Ocular Therapeutix Inc (Akcie OCUL)

Finanční výsledky akcie OCUL

Tento článek patří k prémiovému obsahu našeho webu.

Roční předplatné

Čtvrtletní předplatné

Měsíční předplatné

Porovnání s konkurencí: Akcie OCUL

Nedávné obchody insiderů: Akcie OCUL

Diskuze k akciím OCUL